HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Elisa Lucchini Selected Research
Elisa Lucchini Research Topics
Disease
7
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2023 - 04/2017
3
COVID-19
01/2023 - 01/2022
2
Multiple Myeloma
11/2023 - 01/2023
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2023 - 12/2021
2
Hodgkin Disease (Hodgkin's Disease)
01/2023 - 06/2021
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 01/2022
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2022 - 01/2022
2
Hemorrhage
01/2021 - 12/2018
1
Prolymphocytic Leukemia
01/2024
1
Lymphoma (Lymphomas)
01/2023
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023
1
Neoplasms (Cancer)
01/2023
1
Hematologic Neoplasms (Hematological Malignancy)
01/2023
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022
1
Leukemia
04/2022
1
Persistent Infection
01/2022
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2019
1
Autoimmune Diseases (Autoimmune Disease)
01/2019
1
Infections
12/2018
1
Thrombosis (Thrombus)
12/2018
1
Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2018
1
Encephalitis (Encephalitis, Rasmussen)
12/2017
Drug/Important Bio-Agent (IBA)
5
venetoclax
IBA
01/2024 - 01/2021
5
Inosine Triphosphate (ITP)
IBA
01/2021 - 04/2017
4
Rituximab (Mabthera)
FDA Link
12/2022 - 04/2017
3
Thrombopoietin Receptors
IBA
01/2023 - 01/2021
3
eltrombopag
FDA Link
01/2021 - 12/2018
2
ibrutinib
IBA
01/2024 - 01/2023
2
Lenalidomide (CC 5013)
FDA Link
01/2023 - 01/2023
2
Bendamustine Hydrochloride
FDA Link
12/2022 - 12/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2023
1
BNT162 Vaccine
IBA
01/2023
1
Messenger RNA (mRNA)
IBA
01/2023
1
Vaccines
IBA
01/2023
1
polatuzumab vedotin
IBA
12/2022
1
Monoclonal Antibodies
IBA
01/2022
1
Viral RNA
IBA
01/2022
1
casirivimab and imdevimab drug combination
IBA
01/2022
1
Cytarabine (Cytosar-U)
FDA Link
Generic
12/2021
1
pembrolizumab
IBA
06/2021
1
Immune Checkpoint Inhibitors
IBA
06/2021
1
Nivolumab
IBA
06/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
romiplostim
FDA Link
12/2018
1
Anticoagulants
IBA
12/2018
1
Bortezomib (Velcade)
FDA Link
01/2018
1
Ganciclovir (Cytovene)
FDA Link
Generic
12/2017
1
Valganciclovir
FDA Link
12/2017
Therapy/Procedure
5
Therapeutics
01/2023 - 12/2018
4
Salvage Therapy
11/2023 - 04/2017
2
Splenectomy
01/2023 - 01/2019
1
Stem Cell Transplantation
01/2023
1
Radiotherapy
06/2021
1
Hematopoietic Stem Cell Transplantation
12/2017